Immunogenicity of yellow fever vaccine co-administered with 13-valent pneumococcal conjugate vaccine in rural Gambia: A cluster-randomised trial. [PDF]
Osei I+12 more
europepmc +1 more source
PHV15: CLINICAL AND ECONOMIC BENEFITS OF THE PNEUMOCOCCAL CONJUGATE VACCINE IN CHILDREN
Gerry Oster+4 more
openalex +1 more source
Research priorities to support typhoid conjugate vaccine decision-making in India: evidence assessment and stakeholder survey. [PDF]
Mogasale VV+10 more
europepmc +1 more source
Field Effectiveness of a Typhoid Conjugate Vaccine: The 2018 Navi Mumbai Pediatric TCV Campaign. [PDF]
Date K+29 more
europepmc +1 more source
Cost-Effectiveness Analysis of the Use of V116, a 21-Valent Pneumococcal Conjugate Vaccine, in Vaccine-Naïve Adults Aged ≥ 65 Years in the United States. [PDF]
Yi Z, Owusu-Edusei K, Elbasha E.
europepmc +1 more source
Post-licensure Safety Surveillance of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among US Adults in the Vaccine Adverse Event Reporting System (VAERS). [PDF]
Oliveira M+7 more
europepmc +1 more source
Effect of 10-valent pneumococcal conjugate vaccine on trends of pneumococcal meningitis in children under five years, Uganda, 2003-2022. [PDF]
Nuwamanya Y+10 more
europepmc +1 more source